London, Dec 27 (AFP/APP): The Covid-19 vaccine developed by the British drugs group AstraZeneca and the University of Oxford has achieved a “winning formula” for efficacy, the company’s chief executive said on Sunday. The vaccine, which is currently being evaluated by Britain’s independent medicines regulator, provides “100 percent protection” against severe Covid disease requiring hospitalization, Pascal Soriot said in an interview with the Sunday Times newspaper. He added he believes trials will show his firm has achieved a vaccine efficacy equal to Pfizer-BioNTech at 95 percent and Moderna at 94.5 percent. “We think we have figured out the winning formula … Continue reading Covid Vaccine Developed in UK